News
DRTSW
0.2147
+11.47%
0.0221
ALPHA TAU ANNOUNCES APPOINTMENT OF MAYA NETSER TO ITS BOARD OF DIRECTORS; BOARD MEMBER MEIR JAKOBSOHN STEPPING DOWN, STAYING ON AS ADVISOR
Reuters · 1d ago
Weekly Report: what happened at DRTSW last week (1209-1213)?
Weekly Report · 2d ago
Weekly Report: what happened at DRTSW last week (1202-1206)?
Weekly Report · 12/09 09:57
Weekly Report: what happened at DRTSW last week (1125-1129)?
Weekly Report · 12/02 09:58
Weekly Report: what happened at DRTSW last week (1118-1122)?
Weekly Report · 11/25 09:54
BRIEF-Alpha Tau Medical Announces Third Quarter 2024 Financial Results
Reuters · 11/19 22:21
ALPHA TAU MEDICAL LTD: CASH RUNWAY OF AT LEAST TWO YEARS
Reuters · 11/19 21:00
Weekly Report: what happened at DRTSW last week (1111-1115)?
Weekly Report · 11/18 09:53
Weekly Report: what happened at DRTSW last week (1104-1108)?
Weekly Report · 11/11 09:58
Weekly Report: what happened at DRTSW last week (1028-1101)?
Weekly Report · 11/04 09:58
Weekly Report: what happened at DRTSW last week (1021-1025)?
Weekly Report · 10/28 09:54
ALPHA TAU ANNOUNCES ACCEPTANCE INTO FDA’S TOTAL PRODUCT LIFE CYCLE ADVISORY PROGRAM TO ACCELERATE MARKET ACCESS TO ALPHA DART® FOR PATIENTS WITH RECURRENT GLIOBLASTOMA MULTIFORME
Reuters · 10/21 12:30
Weekly Report: what happened at DRTSW last week (1014-1018)?
Weekly Report · 10/21 09:53
Weekly Report: what happened at DRTSW last week (1007-1011)?
Weekly Report · 10/14 10:04
Weekly Report: what happened at DRTSW last week (0930-1004)?
Weekly Report · 10/07 10:00
Weekly Report: what happened at DRTSW last week (0923-0927)?
Weekly Report · 09/30 09:57
Weekly Report: what happened at DRTSW last week (0916-0920)?
Weekly Report · 09/23 09:56
ALPHA TAU ANNOUNCES FDA APPROVAL OF IDE TO INITIATE MULTI-CENTER INVESTIGATOR-INITIATED STUDY OF ALPHA DART® IN IMMUNOCOMPROMISED PATIENTS WITH RECURRENT CSCC
Reuters · 09/20 12:30
Weekly Report: what happened at DRTSW last week (0909-0913)?
Weekly Report · 09/16 09:52
Weekly Report: what happened at DRTSW last week (0902-0906)?
Weekly Report · 09/09 09:57
More
Webull provides a variety of real-time DRTSW stock news. You can receive the latest news about Alpha Tau Medical Ltd through multiple platforms. This information may help you make smarter investment decisions.
About DRTSW
Alpha Tau Medical Ltd is an Israel-based medical technology company that focuses on research, development and commercialization of Alpha DaRT Diffusing Alpha-emitters Radiation Therapy (Alpha DaRT) for the treatment of solid cancer. Company's technology relies on the diffusion of atoms that emit alpha particles within the tumor tissue, and enables alpha radiation to reach the the entire tumor. Precise amounts of radioactive radium-224 affixed that emit short-range alpha radiation enables to damages and kills cancer cells within a short period of time. The Company has one subsidiary Healthcare Capital Corp.